Background Nomogram, a visual clinical predictive model, provides a scientific basis for
clinical decision making. Herein, we investigated 20 years of nomogram research …

As an epitranscriptomic modulation manner, N6‐methyladenosine (m6A) modification plays
important roles in various diseases, including hepatocellular carcinoma (HCC). m6A …

The emergence of RNA modifications has recently been considered as critical post-
transcriptional regulations which governed gene expression. N 6-methyladenosine (m 6 A) …

The epigenetic regulation of N6-methyladenosine (m6A) has attracted considerable interest
in tumor research, but the potential roles of m6A regulator-related genes, remain largely …

Background Cholangiocarcinoma (CCA) is a serious malignancy originating from the bile
ducts and the second most common primary liver cancer. Long non-coding RNA (lncRNA) is …

Simple Summary Hepatocellular carcinoma (HCC) is known for its poor prognosis, but the
markers for prognosis still remain unclear to date. This study focused on the long non-coding …

As the most prevalent epitranscriptomic modification, N6-methyladenosine (m6A) shows
important roles in a variety of diseases through regulating the processing, stability and …

Background Accurate prognosis is crucial for improving hepatocellular carcinoma (HCC)
patients, clinical management, and outcomes post-liver resection. However, the lack of …

Abstract N6-methyladenosine (m6A) is one of the most common internal modifications in
eukaryotic RNA. The presence of m6A on transcripts can affect a series of fundamental …